Speakers & Panel Members

Keynote Speaker
Dr. Dan Zabrowski
Dr. Dan Zabrowski
Global Head, Roche Partnering
Speakers
Dr. Luca Benatti
Dr. Luca Benatti
CEO, Newron Pharmaceuticals S.p.A.
Dr. Christof Böhler
Dr. Christof Böhler
CEO, Pantec Biosolutions AG
Luca Bolliger
Luca Bolliger
Director Business Development, NovImmune SA
Enrico Braglia
Enrico Braglia
CEO, SeneXta Therapeutics SA
Dr. Michael Buschle
Dr. Michael Buschle
President - Biologics, Glenmark Pharmaceuticals SA
Dr. Hamish Cameron
Dr. Hamish Cameron
CEO, Delenex Therapeutics AG
Dr. David Deperthes
Dr. David Deperthes
CEO, Meddiscovery SA
Dimitri F. Dimitriou
Dimitri F. Dimitriou
CEO, ImmuPharma AG
Tim Dyer
Tim Dyer
CFO & Co-Founder, Addex Pharmaceuticals Ltd.
Abel Ferrández
Abel Ferrández
Head of R&D, Pentapharm
Neil Goldsmith
Neil Goldsmith
CEO, Evolva Holding SA
Dr. Frank Grossmann
Dr. Frank Grossmann
CEO, Orphanbiotec AG
Roland Haefeli
Roland Haefeli
Head of Investor Relations & Public Affairs, Actelion Pharmaceuticals Ltd.
Dr. Friedrich Heitger
Dr. Friedrich Heitger
Managing Director, Arrayon Biotechnology SA
Dr. Corinne John
Dr. Corinne John
CSO, Redbiotec AG
Michael Mulqueen
Michael Mulqueen
Vice President Operations, Synosia Therapeutics AG
Christophe D. Reymond
Christophe D. Reymond
Chief Scientific Officer, Anergis SA
Prof. Bernhard Ryffel
Prof. Bernhard Ryffel
Scientific advisor, Phenotec AG
Dr. Christian Schaub
Dr. Christian Schaub
CEO, Redbiotec AG
Dr. Klaus Schollmeier
Dr. Klaus Schollmeier
CEO, Santhera Pharmaceuticals Holding AG
Dr. Chris Stern
Dr. Chris Stern
CEO, Oxygen Biotherapeutics, Inc.
Chris Tanner
Chris Tanner
Executive Director CFO, Cosmo Pharmaceuticals S.p.A.
Dr. Christian Zahnd
Dr. Christian Zahnd
CEO, Molecular Partners AG
Presentation of the Swiss Biotech Report 2010 (followed by a panel discussion)
Jürg Zürcher
Jürg Zürcher
Representative, Steering Committee of the Swiss Biotech Report 2010
Panel Discussion: Swiss Biotech Report 2010
Dr. Reinhard Glück
Dr. Reinhard Glück
President, Swiss Biotech Association
Dr. Dan Zabrowski
Dr. Dan Zabrowski
Global Head, Roche Partnering
Jürg Zürcher
Jürg Zürcher
Representative, Steering Committee of the Swiss Biotech Report 2010
Speech: What Pharma is really looking for: A review of the recent deal-making at pharma and biotech
Dr. Chris Britten
Dr. Chris Britten
Director Corporate Finance , Deloitte
Michael G. McCully
Michael G. McCully
Deloitte Recap LLC, Deloitte
Panel Discussion: Pharma and biotech regulation: Is Switzerland falling behind?
Dr. Christoph Koellreuter
Dr. Christoph Koellreuter
Director and Delegate, metrobasel
Dr. Stefan Kohler
Dr. Stefan Kohler
Partner , VISCHER AG
Dr. Matthias Staehelin
Dr. Matthias Staehelin
Partner, VISCHER AG
Speech: Current financing trends (followed by a panel discussion)
Dr. Dominik Escher
Dr. Dominik Escher
Managing Director and V R&D, ESBATech
Panel Discussion: Current financing trends
Dr. Reinhard J. Ambros
Dr. Reinhard J. Ambros
CEO, Novartis Venture Funds
Dr. Dominik Escher
Dr. Dominik Escher
CEO, ESBATech
Nilesh Kumar
Nilesh Kumar
Associate Director, Merck Serono Ventures
Dr. Gerhard Ries
Dr. Gerhard Ries
General Partner, BioMedPartners AG
Dr. Christian Zahnd
Dr. Christian Zahnd
CEO , Molecular Partners AG
Moderators
Dr. Holger Bengs
Dr. Holger Bengs
Lidia Pititto
Lidia Pititto
Event Manager, Issuer Relations, SIX Swiss Exchange
Björn Zern
Björn Zern
Chief Editor, Swiss Equity magazin